Track genome-wide copy number variation

for safer cell therapy development and better insights into cancer drivers.

Speak to scientist

DNA Is Our Foundation

Providing cancer researchers with the only single-cell technology that simultaneously measures single nucleotide variation (SNV), copy number variation (CNV), and protein data from the same cells. Our multi-omics platform connects genotype and phenotype in each cell, dissecting the architecture of tumors with unprecedented resolution.

Single-cell Genomics (DNA)

SNV

Leverage single-cell technology to detect rare clonal populations and identify co-occurrence and zygosity.

LEARN MORE

SNV + CNV

Characterize genetic and copy number aberrations using a single comprehensive platform.

LEARN MORE

Single-cell Multi-omics (DNA + Protein)

DNA + Protein

Gain a true multi-omics picture from genotype to phenotype.

LEARN MORE

PRODUCTS

The Tapestri Platform

The first and only single-cell technology developed to reveal biomarkers that help stratify patients, signal resistance, and predict relapse. Tapestri’s powerful multi-omics capability — connecting genotype and phenotype — opens the door to a deeper understanding and improved treatment of cancer.

Tapestri product image with an instrument, reagent kit and analysis software displaying a fish plot

Tapestri Platform

An end-to-end workflow from sample preparation to visualization with publication-ready insights for single-cell sequencing analysis.

LEARN MORE

Panels

Targeted panels provide focus on key regions of interest for efficient use of sequencing budget and analysis time.

LEARN MORE

Track genome-wide copy number variation

Introducing Tapestri Single-cell Multiomics Solution for Multiple Myeloma

Develop Safer CRISPR-based Advanced Therapies with the Genome Editing Solution

Pharma Assay Development Services – Your Single-cell Technology Partner Across Therapeutic Development and Manufacturing

DNA Is Our Foundation

The Tapestri Platform

News

Events

Featured Resources